Sanjeev Narula - 02 Jan 2026 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Reporting relationship: Chief Financial & Bus. Officer
Issuer ticker: PHAT
Reported as of: 02 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jan 2026, 17:42:34 UTC
Prior SEC filing: 07 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula

Key filing fact

Sanjeev Narula filed Form 4 for Phathom Pharmaceuticals, Inc. (PHAT) on 02 Jan 2026.

Key facts

This page summarizes Sanjeev Narula's Form 4 filing for Phathom Pharmaceuticals, Inc. (PHAT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jan 2026, 17:42.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001820590 Primary reporting owner

Narula Sanjeev

Relationship: Chief Financial & Bus. Officer
Address: C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK
Signature: /s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula
Signature date: 02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHAT transaction

Common Stock

Award

Transaction value: $0
Shares: +82,715
Change %: +57%
Price: $0.000000
Shares after: 226,715
Date: 02 Jan 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHAT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +42,848
Change %
Price: $0.000000
Shares after: 42,848
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 42,848
Exercise price: $15.71
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Footnote F2

1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.